Back to DS Daiwa Securities Group Inc.
MCRB
Showing 0 of 17 quarters
Position history for DSDaiwa Securities Group Inc.'s holdings in Seres Therapeutics, Inc.
No. Daiwa Securities Group exited its MCRB (Seres Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 501 shares worth $1,000. Daiwa Securities Group held MCRB in 16 quarterly 13F filings before exiting.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
—
No position history available for this security.